BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14534300)

  • 1. Multiple states of stalled T7 RNA polymerase at DNA lesions generated by platinum anticancer agents.
    Jung Y; Lippard SJ
    J Biol Chem; 2003 Dec; 278(52):52084-92. PubMed ID: 14534300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
    Ang WH; Myint M; Lippard SJ
    J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior of T7 RNA polymerase and mammalian RNA polymerase II at site-specific cisplatin adducts in the template DNA.
    Tornaletti S; Patrick SM; Turchi JJ; Hanawalt PC
    J Biol Chem; 2003 Sep; 278(37):35791-7. PubMed ID: 12829693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins.
    Wei M; Cohen SM; Silverman AP; Lippard SJ
    J Biol Chem; 2001 Oct; 276(42):38774-80. PubMed ID: 11514569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of DNA--platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases.
    Corda Y; Job C; Anin MF; Leng M; Job D
    Biochemistry; 1993 Aug; 32(33):8582-8. PubMed ID: 7689335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of platinum-DNA adduct repair.
    Chaney SG; Vaisman A
    J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.
    Zhu G; Chang P; Lippard SJ
    Biochemistry; 2010 Jul; 49(29):6177-83. PubMed ID: 20550106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
    Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
    Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
    Zhu G; Myint M; Ang WH; Song L; Lippard SJ
    Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
    Corda Y; Anin MF; Leng M; Job D
    Biochemistry; 1992 Feb; 31(7):1904-8. PubMed ID: 1536834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
    Malina J; Natile G; Brabec V
    Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.
    Spingler B; Whittington DA; Lippard SJ
    Inorg Chem; 2001 Oct; 40(22):5596-602. PubMed ID: 11599959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK; So WK; Ho YP; Au-Yeung CF
    Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
    Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
    Zaludová R; Zákovská A; Kasparková J; Balcarová Z; Kleinwächter V; Vrána O; Farrell N; Brabec V
    Eur J Biochem; 1997 Jun; 246(2):508-17. PubMed ID: 9208945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner.
    Perlow RA; Kolbanovskii A; Hingerty BE; Geacintov NE; Broyde S; Scicchitano DA
    J Mol Biol; 2002 Aug; 321(1):29-47. PubMed ID: 12139931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein interactions with platinum-DNA adducts: from structure to function.
    Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
    J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
    Kasparkova J; Vojtiskova M; Natile G; Brabec V
    Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
    Reardon JT; Vaisman A; Chaney SG; Sancar A
    Cancer Res; 1999 Aug; 59(16):3968-71. PubMed ID: 10463593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
    Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.